CM
ADCT icon

Caption Management’s ADC Therapeutics ADCT Stock Holding History

Caption Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,925
Closed -$50.3K – 1236
2024
Q2 		$50.3K Buy
+15,925
New +$63.3K ﹤0.01% 1058
2021
Q3 		– Sell
-42,500
Closed -$1.03M – 1463
2021
Q2 		$1.03M Sell
42,500
-40,500
-49% -$940K 0.01% 881
2021
Q1 		$2.03M Buy
+83,000
New +$2.4M 0.04% 510

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Caption Management's ADCT Position: Q3 2024 in Review

Caption Management sold out of ADC Therapeutics (ADCT) in Q3 2024, closing a stake of 15,925 shares — an estimated $50.3K sold.

Caption Management first reported a position in ADCT in Q1 2021 and held it in 3 quarters. The position peaked at $2.03M in Q1 2021. 77 funds tracked by Wall St. Rank hold ADCT as of Q3 2024.

  • Caption Management reported no remaining ADC Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 15,925 ADC Therapeutics shares in Q3 2024, an estimated $50.3K.
  • Caption Management first reported a position in ADC Therapeutics in Q1 2021 and held it in 3 quarters.
  • Caption Management's ADC Therapeutics position peaked at $2.03M in Q1 2021.
  • 77 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.